(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...

Energy equipment and services provider Flowco launched the year’s first major IPO, planning to raise $392 million and list in ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

Stay away from Diginex Limited's IPO due to declining revenue, high debt, and intense competition in the ESG market. Read ...

The SPAC is offering up to $8.3 million worth of private placement units, committed by sponsors and independent director nominees. It also has provided 7.2 million Class B shares to initial ...

Jesons Industries IPO comprises of fresh issuance of equity shares worth Rs 300 crore, and an offer-for-sale of 94.6 lakh ...

Chandhiok & Mahajan assisted Mangal Electrical Industries Limited on its filing a Draft Red Herring Prospectus for the ...

Jesons Industries Ltd. on Friday refiled its preliminary papers with the Securities and Exchange Board of India to raise ...

The IPO, with a face value of ₹5 per share, comprises a fresh issue worth up to ₹300 crore and an offer for sale of 9.46 ...

The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Flowco - Houston, 17.8 million shares, priced at ...

Metsera files for IPO, developing GLP-1 drug MET-097i and other obesity treatments to compete with Eli Lilly and Novo Nordisk ...

Sat Kartar Shopping's maiden public issue recorded 4.5 times subscription on Friday, with investors buying 1.34 crore equity ...